Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RRP7A Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA551604
Description
Immunogen sequence: VRQGTKSTWP QKRTLFVLNV PPYCTEESLS RLLSTCGLVQ SVELQEKPDL AESPKESRSK FFHPKPVPGF QVAYVVFQKP SGVSAALALK GPLLVSTESH PVKSGIHKWI SDYA Highest antigen sequence identity to the following orthologs: Mouse - 84%, Rat - 84%.
RRP7A (Ribosomal RNA Processing 7 Homolog A) is a Protein Coding gene. Diseases associated with RRP7A include Autosomal Dominant Non-Syndromic Intellectual Disability 1 and Autosomal Dominant Non-Syndromic Intellectual Disability. Among its related pathways are rRNA processing in the nucleus and cytosol and Gene Expression. Gene Ontology (GO) annotations related to this gene include nucleotide binding. [GeneCards].
Specifications
RRP7A | |
Polyclonal | |
Unconjugated | |
RRP7A | |
1110014J01Rik; AA408146; BK126B4.3; CGI-96; CTA-126B4.5; gastric cancer antigen Zg14; Gastric cancer antigen Zg14 homolog; hypothetical protein LOC550241; Kheg1; kidney highly expressed protein 1; RGD1311547; ribosomal RNA processing 7 homolog; ribosomal RNA processing 7 homolog A; ribosomal RNA processing 7 homolog A (S. cerevisiae); ribosomal RNA-processing protein 7 homolog A; RRP7; RRP7A; zgc:110084 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
27341 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry, Western Blot | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9Y3A4 | |
RRP7A | |
Recombinant protein corresponding to Human RRP7A. Recombinant protein control fragment (Product #RP-91482). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction